SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Satwani P.)
 

Sökning: WFRF:(Satwani P.) > Subsequent neoplasm...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00011179naa a2201009 4500
001oai:DiVA.org:uu-413865
003SwePub
008200621s2020 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:143684647
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4138652 URI
024a https://doi.org/10.1182/bloodadvances.20190008392 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1436846472 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Kahn, Justine M.u Columbia Univ, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, New York, NY 10027 USA.4 aut
2451 0a Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases
264 c 2020-05-12
264 1b AMER SOC HEMATOLOGY,c 2020
338 a print2 rdacarrier
520 a We examined the risk of subsequent neoplasms (SNs) and late mortality in children and adolescents undergoing allogeneic hematopoietic cell transplantation (HCT) for nonmalignant diseases (NMDs). Weincluded 6028 patients (median age, 6 years; interquartile range, 1-11; range, <1 to 20) from the Center for International Blood and Marrow Transplant Research (1995-2012) registry. Standardized mortality ratios (SMRs) in 2-year survivors and standardized incidence ratios (SIRs) were calculated to compare mortality and SN rates with expected rates in the general population. Median follow-up of survivors was 7.8 years. Diagnoses included severe aplastic anemia (SAA; 24%), Fanconi anemia (FA; 10%), other marrow failure (6%), hemoglobinopathy (15%), immunodeficiency (23%), and metabolic/leukodystrophy syndrome (22%). Ten-year survival was 93% (95% confidence interval [95% CI], 92% to 94%; SMR, 4.2; 95% CI, 3.7-4.8). Seventy-one patients developed SNs (1.2%). Incidence was highest in FA (5.5%), SAA (1.1%), and other marrow failure syndromes (1.7%); for other NMDs, incidence was <1%. Hematologic (27%), oropharyngeal (25%), and skin cancers (13%) were most common. Leukemia risk was highest in the first 5 years posttransplantation; oropharyngeal, skin, liver, and thyroid tumors primarily occurred after 5 years. Despite a low number of SNs, patients had an 11-fold increased SN risk (SIR, 11; 95% CI, 8.9-13.9) compared with the general population. We report excellent long-term survival and low SN incidence in an international cohort of children undergoing HCT for NMDs. The risk of SN development was highest in patients with FA and marrow failure syndromes, highlighting the need for long-term posttransplantation surveillance in this population.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng
700a Brazauskas, Rutau Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA.4 aut
700a Tecca, Heather R.u Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.4 aut
700a Bo-Subait, Stephanieu Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.4 aut
700a Buchbinder, Davidu Childrens Hosp Orange Cty, Div Pediat Hematol, Orange, CA 92668 USA.4 aut
700a Battiwala, Minoou Sarah Cannon Bone & Marrow Transplant Program, Hematol Branch, Nashville, TN USA.4 aut
700a Flowers, Mary E. D.u Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA.4 aut
700a Savani, Bipin N.u Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA.4 aut
700a Phelan, Rachelu Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Dept Pediat, Div Pediat Hematol Oncol BMT, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.4 aut
700a Broglie, Larisau Columbia Univ, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, New York, NY 10027 USA.4 aut
700a Abraham, Allistair A.u Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Div Blood & Marrow Transplantat, Washington, DC 20010 USA.4 aut
700a Keating, Amy K.u Childrens Hosp Colorado, Aurora, CO USA.;Univ Colorado, Aurora, CO USA.4 aut
700a Daly, Andrewu Tom Baker Canc Clin, Calgary, AB, Canada.4 aut
700a Wirk, Baldeepu Seattle Canc Alliance, Div Bone Marrow Transplant, Seattle, WA USA.4 aut
700a George, Bijuu Christian Med Coll & Hosp, Dept Hematol, Vellore, Tamil Nadu, India.4 aut
700a Alter, Blanche P.u NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.4 aut
700a Ustun, Celalettinu Rush Univ, Div Hematol Oncol Cell Therapy, Chicago, IL 60612 USA.4 aut
700a Freytes, Cesar O.u Texas Transplant Inst, San Antonio, TX USA.4 aut
700a Beitinjaneh, Amer M.u Univ Miami Hlth Syst, Sylvester Comprehens Canc Ctr, Miami, FL USA.4 aut
700a Duncan, Christineu Boston Childrens Hosp, Dept Pediat Oncol, Boston, MA USA.;Dana Farber Canc Inst, Boston, MA 02115 USA.4 aut
700a Copelan, Edwardu Atrium Hlth, Levine Canc Inst, Carolinas HealthCare Syst, Charlotte, NC USA.4 aut
700a Hildebrandt, Gerhard C.u Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.4 aut
700a Murthy, Hemant S.u Univ Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA.4 aut
700a Lazarus, Hillard M.u Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Med, Cleveland, OH 44106 USA.;Case Western Reserve Univ, Case Comprehens Canc Ctr, Seidman Canc Ctr, Cleveland, OH 44106 USA.4 aut
700a Auletta, Jeffery J.u Nationwide Childrens Hosp, Div Hematol Oncol Bone Marrow Transplant & Infect, Blood & Marrow Transplant Program, Columbus, OH USA.;Nationwide Childrens Hosp, Div Hematol Oncol Bone Marrow Transplant & Infect, Host Def Program, Columbus, OH USA.4 aut
700a Myers, Kasiani C.u Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.;Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA.4 aut
700a Williams, Kirsten M.u Childrens Natl Hlth Syst, Childrens Res Inst, Washington, DC USA.4 aut
700a Page, Kristin M.u Duke Univ, Med Ctr, Div Pediat Blood & Marrow Transplantat, Durham, NC USA.4 aut
700a Vrooman, Lynda M.u Boston Childrens Hosp, Dept Pediat Oncol, Boston, MA USA.;Dana Farber Canc Inst, Boston, MA 02115 USA.4 aut
700a Norkin, Maximu Univ Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA.4 aut
700a Byrne, Michaelu Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA.4 aut
700a Diaz, Miguel Angelu Hosp Infantil Univ Nino Jesus, Dept Hematol Oncol, Madrid, Spain.4 aut
700a Kamani, Nayneshu Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA.4 aut
700a Bhatt, Neel S.u St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.4 aut
700a Rezvani, Andrewu Stanford Hlth Care, Stanford, CA USA.4 aut
700a Farhadfar, Noshau Univ Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA.4 aut
700a Mehta, Parinda A.u Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.;Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA.4 aut
700a Hematti, Peimanu Univ Wisconsin, Dept Med, Div Hematol Oncol Bone Marrow Transplantat, Madison, WI USA.4 aut
700a Shaw, Peter J.u Childrens Hosp Westmead, Westmead, NSW, Australia.4 aut
700a Kamble, Rammurti T.u Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA.4 aut
700a Schears, Raquelu Mayo Clin, Div Hematol Bone Marrow Transplant, Rochester, MN USA.4 aut
700a Olsson, Richardu Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Lab Med, Stockholm, Sweden4 aut0 (Swepub:uu)riols677
700a Hayashi, Robert J.u Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA.4 aut
700a Gale, Robert Peteru Imperial Coll London, Hematol Res Ctr, Dept Med, Div Expt Med, London, England.4 aut
700a Mayo, Samantha J.u Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada.4 aut
700a Chhabra, Saurabhu Med Coll Wisconsin, Dept Pediat, Div Pediat Hematol Oncol BMT, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.4 aut
700a Rotz, Seth J.u Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.;Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA.4 aut
700a Badawy, Sherif M.u Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL 60611 USA.;Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.4 aut
700a Ganguly, Siddharthau Univ Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA.4 aut
700a Pavletic, Stevenu NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.4 aut
700a Nishihori, Taigau H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL USA.4 aut
700a Prestidge, Timu Starship Childrens Hosp, Blood & Canc Ctr, Auckland, New Zealand.4 aut
700a Agrawal, Vaibhavu Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA.4 aut
700a Hogan, William J.u Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA.;Mayo Clin, Div Hematol Bone Marrow Transplant, Rochester, MN USA.4 aut
700a Inamoto, Yoshihirou Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan.4 aut
700a Shaw, Bronwen E.u Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.4 aut
700a Satwani, Prakashu Columbia Univ, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, New York, NY 10027 USA.4 aut
710a Columbia Univ, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, New York, NY 10027 USA.b Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA.;Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA.4 org
773t Blood Advancesd : AMER SOC HEMATOLOGYg 4:9, s. 2084-2094q 4:9<2084-2094x 2473-9529x 2473-9537
856u https://ashpublications.org/bloodadvances/article-pdf/4/9/2084/1728713/advancesadv2019000839.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-413865
8564 8u https://doi.org/10.1182/bloodadvances.2019000839
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:143684647

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy